Listen to an interview about my work on the policy implications of existing evidence for an association between the CPT1A P479L variant and infant death.

Current: Ongoing research projects include opportunities for pharmacogenetic testing in healthcare systems to improve patient centered outcomes, and machine learning in electronic health record data to characterize patient phenotypes.

Doctoral Research:  My previous work emerged out of a partnership between the Northwest-Alaska Pharmacogenomics Research Network, the Yup’ik people in Alaska, the Yukon Kuskokwim Health Corporation, the Center for Alaska Native Health Research in Fairbanks, and the Southcentral Foundation in Anchorage. It focused on associations of genetics, diet, and sunlight exposure on circulating vitamin D levels, and how these variables may alter response to certain medications.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s